DAHC, AXDEV Global, Pfizer partner for chronically ill patients’ enhanced care

DAHC, AXDEV Global, Pfizer partner for chronically ill patients’ enhanced care

Dubai: The Dubai Academic Health Corporation, AXDEV Global, and Pfizer Global announced a public-private partnership to enhance care for patients diagnosed with chronic illnesses, supported by an independent grant from Pfizer Global Medical Grants. The collaboration aims to establish an evidence-based model in performance and quality improvement to support the adoption of best practices and boost capacity development for patient care with chronic illnesses at the individual, team, practice, and health systems levels. The findings will then be scaled to enhance chronic illness care in low- and middle-income countries (LMICs) in Asia-Pacific, the Middle East, and North Africa. The Dubai Academic Health Corporation will host the initiative at its medical university, Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), and AXDEV will provide expert implementation research and project management across every step of the program. “Accessible healthcare for patients living with chronic illnesses is critical given that they are tethered to the healthcare system,” said Yasser El Dershaby, Vice President, MERA Regional Cluster Medical Lead, Pfizer. “Our new public-private partnership with The Dubai Academic Health Corporation and AXDEV Global brings us one step closer to bridging these gaps.” Through a research project out of MBRU, the research will